These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7655702)

  • 1. Changing patterns in asthma morbidity and mortality.
    Sears MR
    J Investig Allergol Clin Immunol; 1995; 5(2):66-72. PubMed ID: 7655702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.
    Sears MR; Taylor DR
    Drug Saf; 1994 Oct; 11(4):259-83. PubMed ID: 7848546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiologic studies of beta agonists and asthma deaths.
    Pearce N; Hensley MJ
    Epidemiol Rev; 1998; 20(2):173-86. PubMed ID: 9919437
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of beta-agonists and the risk of death and near death from asthma.
    Spitzer WO; Suissa S; Ernst P; Horwitz RI; Habbick B; Cockcroft D; Boivin JF; McNutt M; Buist AS; Rebuck AS
    N Engl J Med; 1992 Feb; 326(8):501-6. PubMed ID: 1346340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992.
    Lanes SF; Birmann B; Raiford D; Walker AM
    J Clin Epidemiol; 1997 Mar; 50(3):321-8. PubMed ID: 9120532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-acting beta-agonist research: a perspective. 1997.
    Sears MR
    Can Respir J; 2001; 8(5):349-55. PubMed ID: 11694915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in bronchodilator therapy.
    Nelson HS
    Curr Opin Pulm Med; 1996 Jan; 2(1):35-9. PubMed ID: 9363113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic.
    Suissa S; Ernst P
    J Clin Epidemiol; 1997 Oct; 50(10):1079-88. PubMed ID: 9368515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma. Bronchodilators: new developments.
    Tattersfield AE
    Br Med Bull; 1992 Jan; 48(1):190-204. PubMed ID: 1352168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity.
    Garrett JE; Lanes SF; Kolbe J; Rea HH
    Thorax; 1996 Nov; 51(11):1093-9. PubMed ID: 8958891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a problem with inhaled long-acting beta-adrenergic agonists?
    Nelson HS
    J Allergy Clin Immunol; 2006 Jan; 117(1):3-16; quiz 17. PubMed ID: 16387577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-2 agonist discussions in asthma and a review of current data.
    Erdinç M
    Tuberk Toraks; 2011; 59(2):205-12. PubMed ID: 21740399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs.
    Corrao G; Zambon A; Faini S; Bagnardi V; Leoni O; Suissa S
    J Clin Epidemiol; 2005 Jan; 58(1):92-7. PubMed ID: 15649676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing asthma mortality and sales of inhaled bronchodilators and anti-asthmatic drugs.
    Sly RM
    Ann Allergy; 1994 Nov; 73(5):439-43. PubMed ID: 7978538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma.
    Fahy JV; Boushey HA
    Clin Chest Med; 1995 Dec; 16(4):715-33. PubMed ID: 8565410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confounding by indication and channeling over time: the risks of beta 2-agonists.
    Blais L; Ernst P; Suissa S
    Am J Epidemiol; 1996 Dec; 144(12):1161-9. PubMed ID: 8956629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
    Peters S
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The therapeutic potentials of Berotec-100 in bronchial asthma patients].
    Emel'ianov AV; Shevelev SE; Shubin SA; Sinitsina TM; Fedoseev GB
    Klin Med (Mosk); 1998; 76(7):38-9. PubMed ID: 9742777
    [No Abstract]   [Full Text] [Related]  

  • 19. [Round Table: Severe asthma in pediatrics: treatment of acute crises].
    García Martínez JM
    Allergol Immunopathol (Madr); 1999; 27(2):53-62. PubMed ID: 10354007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concluding remarks: can we explain the association of beta-agonists with asthma mortality? A hypothesis.
    Hancox RJ
    Clin Rev Allergy Immunol; 2006; 31(2-3):279-88. PubMed ID: 17085800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.